New hope for Still's disease: experimental drug enters Mid-Stage trial

NCT ID NCT07203001

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a new medicine called MAS825 for people with Still's disease, a rare inflammatory condition causing fever, rash, and joint pain. About 20 children and adults with active disease will receive the drug to see if it safely controls symptoms. The goal is to improve daily life by reducing inflammation and flares.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

juvenile idiopathic arthritis systemic-onset juvenile idiopathic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STILL´S DISEASE

Contacts and locations

Locations

Cincinnati Childrens Hospital
ACTIVE_NOT_RECRUITING

Cincinnati, Ohio, 45229, United States
Legacy Emanuel Research Hosp Portland
RECRUITING

Portland, Oregon, 97232, United States
Novartis Investigative Site
WITHDRAWN

Montreal, Quebec, H3T 1C5, Canada
Novartis Investigative Site
WITHDRAWN

Montreal, Quebec, H4A 3J1, Canada
Novartis Investigative Site
RECRUITING

Bordeaux, 33076, France
Novartis Investigative Site
RECRUITING

Bron, 69677, France
Novartis Investigative Site
RECRUITING

Le Kremlin-Bicêtre, 94275, France
Novartis Investigative Site
RECRUITING

Lille, 59037, France
Novartis Investigative Site
RECRUITING

Paris, 75015, France
Novartis Investigative Site
RECRUITING

Paris, 75970, France
Novartis Investigative Site
RECRUITING

Sankt Augustin, North Rhine-Westphalia, 53757, Germany
Novartis Investigative Site
RECRUITING

Heidelberg, 69120, Germany
Novartis Investigative Site
RECRUITING

Münster, 48149, Germany
Novartis Investigative Site
RECRUITING

Florence, FI, 50139, Italy
Novartis Investigative Site
RECRUITING

Genova, GE, 16147, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00165, Italy
Novartis Investigative Site
RECRUITING

Utrecht, 3584 CX, Netherlands
Novartis Investigative Site
RECRUITING

Esplugues, Barcelona, 08950, Spain
Novartis Investigative Site
RECRUITING

Madrid, 28046, Spain
Novartis Investigative Site
RECRUITING

Valencia, 46026, Spain
Novartis Investigative Site
RECRUITING

Istanbul, Fatih, 34098, Turkey (Türkiye)
Novartis Investigative Site
RECRUITING

Ankara, Sihhiye-Altindag, 06230, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.